Surrozen, Inc.

NASDAQ:SRZN

Biotechnology

Healthcare
$30.67 -4.74%

-$1.14 today

Market cap
$229.33M
Beta
0.51
P/E (TTM)
-0.7
EPS (TTM)
-$31.29
52W Low $8.00High $35.00

Volume 0.09M

Average 0.11M

Income Statement

Follow revenue through to earnings.

Revenue

$3.48M

FY 2025 · Annual

-67.4% YoY

Operating Income

-$42.09M

FY 2025 · Annual

Net Income

-$242.03M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue012.5M010.66M3.48M
Cost of Revenue3.3M3.27M27.23M0537K
Gross Profit(3.3M)9.23M(27.23M)10.66M2.94M
Gross Margin—73.8%—100.0%84.6%
Research & Development36.88M37.01M27.23M21.13M29.37M
Selling, General & Admin14.21M19.83M15.8M15.06M16.2M
Operating Expenses51.09M53.57M18.55M36.19M45.03M
Depreciation & Amortization3.3M1.96M1.91M1.44M537K
EBITDA(51.35M)(34.05M)(41.13M)(62.12M)(241.49M)
EBITDA Margin—-272.4%—-583.0%-6945.3%
Operating Income(54.39M)(44.34M)(45.78M)(25.54M)(42.09M)
Operating Margin—-354.7%—-239.7%-1210.6%
Interest Income72K781K2.34M1.69M3.02M
Interest Expense00000
Other Income / Expenses(257K)8.34M2.74M(38.03M)(199.93M)
Income Before Tax(54.65M)(36M)(43.04M)(63.56M)(242.03M)
Pre-Tax Margin—-288.0%—-596.6%-6960.8%
Income Tax Expense00000
Net Income(52.51M)(36M)(43.04M)(63.56M)(242.03M)
Net Margin—-288.0%—-596.6%-6960.8%
EPS (Basic)(23.40)(15.55)(21.33)(21.67)(32.37)
EPS (Diluted)(23.40)(15.55)(21.33)(21.67)(32.37)
Weighted Avg Shares2.34M2.31M2.02M2.93M7.48M
Weighted Avg Shares (Diluted)2.34M2.31M2.02M2.93M7.48M

SRZN Earnings Waterfall · TTM

NASDAQ:SRZN · Revenue to Net Income

Key Ratios

EPS$-41.33
Gross Margin99.7%
Net Margin-10121.0%
P/E Ratio-0.2
P/S Ratio160.8

Analysis

$7.5M of revenue converted into -$342.6M of net income for the selected period. Gross margin is 99.7% and net margin is -10121.0%, showing how much revenue survives after costs and taxes. EPS is $-41.33, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
FWPFWP filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 13, 2026
8-KCurrent reportNov 9, 2026
10-QQuarterly reportNov 9, 2026
SC 13D/ASC 13D/A filingNov 6, 2026

How much revenue does SRZN generate?

Surrozen, Inc. (SRZN) reported $3.48M of revenue in fiscal 2025.

Is SRZN profitable?

Surrozen, Inc. (SRZN) reported -$242.03M of net income, with a net margin of -6960.8%.